ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

FDA News< Regulations To Ease For Advertising Drugs On TV, Radio

September 12, 1997

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

In Brief: No End Of The Year Hassle His Time – NCI Full Appropriation for FY 1977 Released

November 19, 1976

Interactive RPGs Deadline Is Feb. 20

December 13, 1991

NTP Board Approves Four New Concepts

October 8, 1982

In Brief: NCI To Leave Blair, Landlow Building; House To Hold Hearings March 5 On NCI’s 1998 Budget

February 13, 1987